These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6775583)

  • 1. Sodium valproate and bone marrow suppression.
    Smith FR; Boots M
    Ann Neurol; 1980 Aug; 8(2):197-9. PubMed ID: 6775583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible hepatotoxicity, pancreatitis, coagulation disorder and simultaneous bone marrow suppression with valproate in a 2-year-old girl.
    Gerstner T; Bauer MO; Longin E; Bell N; Koenig SA
    Seizure; 2007 Sep; 16(6):554-6. PubMed ID: 17493839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
    Loisseau P; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
    [No Abstract]   [Full Text] [Related]  

  • 4. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC; Diener W; Kutschke G; Schneble HJ; Korinthenberg R; Sutor AH
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate-associated coagulopathies are frequent and variable in children.
    Attilakos A; Katsarou E; Voudris K; Garoufi A
    Epilepsia; 2007 Jan; 48(1):205-6. PubMed ID: 17241231
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium valproate in epilepsy treatment.
    Brown EG
    Practitioner; 1986 Mar; 230(1413):204. PubMed ID: 3086857
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical results with sodium valproate in childhood and in adolescence].
    Vassella F; Penzien J; Hassink RI; Donati F
    Praxis (Bern 1994); 1994 Oct; 83(40):1117-21. PubMed ID: 7939082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of thrombocytopenia with antiplatelet autoantibody after sodium valproate administration--with statistical analysis of 33 cases administrated sodium valproate].
    Terui T; Ktda K; Mitani T; Terada S; Kure T; Takamura H; Hirayama M; Niitsu Y; Nakazawa O
    Rinsho Ketsueki; 1987 Jun; 28(6):865-71. PubMed ID: 3118077
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychic disturbances associated with sodium valproate plus levetiracetam.
    Siniscalchi A; Gallelli L; De Fazio S; De Sarro G
    Ann Pharmacother; 2007 Mar; 41(3):527-8. PubMed ID: 17327289
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytopenia associated with sodium valproate treatment.
    Neophytides AN; Nutt JG; Lodish JR
    Ann Neurol; 1979 Apr; 5(4):389-90. PubMed ID: 375808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute psychosis associated with levetiracetam.
    Youroukos S; Lazopoulou D; Michelakou D; Karagianni J
    Epileptic Disord; 2003 Jun; 5(2):117-9. PubMed ID: 12875956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations in hemostasis during treatment with sodium dipropylacetate (Depakine) (R)].
    Monnet P; David M; Philippe N; Dechavanne M; Floret D; Renaud H; Trezeciak MC; Brazier JL; Bourdillon D
    Pediatrie; 1979 Sep; 34(6):603-20. PubMed ID: 388337
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sodium valproate, platelet dysfunction and bleeding (author's transl)].
    Loiseau P
    Nouv Presse Med; 1981 Dec; 10(46):3789-90. PubMed ID: 6798554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid and acquired coagulopathy.
    Abdallah C
    Paediatr Anaesth; 2013 Jul; 23(7):674-5. PubMed ID: 23738597
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of sodium valproate in the treatment of partial epilepsy].
    Chadwick D
    Praxis (Bern 1994); 1994 Oct; 83(40):1140-3. PubMed ID: 7939086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate and thrombocytopenia.
    Hoffman LM
    Can Med Assoc J; 1982 Feb; 126(4):358-9. PubMed ID: 6802479
    [No Abstract]   [Full Text] [Related]  

  • 20. Valproate versus carbamazepine for seizures.
    Hernandez-Vidal A
    N Engl J Med; 1993 Jan; 328(3):208. PubMed ID: 8417390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.